Ad
BMRN - BioMarin Pharmaceutical Stock Trading
About | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Not available
Quote | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
| Last: | $91.37 |
|---|---|
| Change Percent: | 0.14% |
| Open: | $92.13 |
| Close: | $91.37 |
| High: | $92.235 |
| Low: | $91.18 |
| Volume: | 621,352 |
| Last Trade Date Time: | 06/09/2023 03:00:00 am |
News | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
-
2023-06-07 08:55:15 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Navigating the turbulent waters in the biotech space is no mean feat. With the sector’s inherent volatility due to testing clinical trials and regulatory hurdles, the road toward market ...
-
2023-06-01 05:16:01 ET Summary Baker Brothers' 13F portfolio value increased from $16.65B to $18.38B, with the largest five stakes in Seagen, Incyte, BeiGene, ACADIA Pharma, and Madrigal Pharma. The firm disposed of its stakes in Ascendis Pharma A/S and Horizon Therapeutics, while...
Message Board Posts | BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
| Subject | By | Source | When |
|---|---|---|---|
| whytestocks: $BMRN News Article - BioMarin Announces Advancements in FDA Review of ROCTAVIAN(TM) (Va | whytestocks | investorshangout | 11/23/2022 2:55:51 PM |
| GRABAR LAW OFFICE INVESTIGATES POTENTIAL DERIVATIVE ACTION ON | jgrabar | investorshub | 04/11/2022 3:40:15 PM |
| whytestocks: $BMRN News Article - Shares of BioMarin Pharmaceutical Inc. (BMRN) Rise to a New 52-Wee | whytestocks | investorshangout | 04/08/2022 5:40:51 PM |
| whytestocks: $BMRN News Article - BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcrip | whytestocks | investorshangout | 10/28/2021 6:55:58 PM |
| whytestocks: $BMRN News Article - European Commission Approves BioMarin's VOXZOGO (vosoritide) for t | whytestocks | investorshangout | 08/27/2021 3:05:59 PM |
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
